Leyue Health
Leyue Health is a medical big data and health insurance technology service provider
About Leyue Health
Leyue Health, legally registered as Leyue Electronic Technology (Shanghai) Co., Ltd., operates within China's burgeoning InsurTech and FinTech sectors. Founded in 2014 by Fuxin Hua, who serves as the legal representative and president, the company has established itself as a key player in bridging the information gap between medical institutions and insurance providers. The firm is headquartered in Beijing and is a subsidiary of Zhongke Leyue Health Technology (Shenzhen) Co., Ltd., which is backed by the Chinese Academy of Sciences.
The company's core business revolves around developing and operating a technology platform that facilitates direct, one-stop settlement for commercial health insurance claims. This service targets both medical institutions, such as hospitals, and insurance companies, streamlining the claims process for policyholders. The platform enables patients to have their medical bills settled in a single interaction at the hospital window, covering public health insurance, commercial insurance, and out-of-pocket payments. This significantly enhances the patient experience by offering a service characterized by zero running around, zero paperwork, zero waiting time, and zero need for upfront payment of the insured amount.
Leyue Health's intelligent settlement platform is a direct response to the complexities and delays inherent in traditional insurance reimbursement procedures. Beyond claims processing, the company provides hospitals with Wi-Fi services and a mobile application that includes features for online appointments, online payments, and management of test results. Since its inception, the company has secured significant funding to fuel its growth, including a Series B round in September 2019 and a Series B1 round in December 2021, with total funding amounting to $17.8M from investors like CCB International, CE Innovation Capital, and Shenzhen Capital Group. These funds are directed towards product research and development, expanding its medical network coverage, and improving its data intelligence capabilities.
Source: Dealroom company dataNews
Open roles
Leyue Health in the Huangpu ecosystem
The Leyue Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Cowin Capital
Shenzhen Capital Group
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Leyue Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Leyue Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

